Ooops... Error 404

Sorry, but the page you are looking for doesn't exist.

Go to the homepage

Meteor Biotech joins brain organoids consortium

biotech Jim Cornall -
Meteor Biotech, which works in spatially resolved cell isolation technologies for advanced biomedical research, is set to participate in a life sciences project in...

Can food influence gene activity?

biotech Jim Cornall -
A new international clinical intervention study published in Clinical Nutrition reveals the molecular and transcriptomic mechanisms through which a dietary intervention may beneficially influence...

Lab-engineered proteins: a promising treatment for liver disease

biotech Jim Cornall -
A research group led by CIC biomaGUNE’s Ikerbasque research professor Aitziber L. Cortajarena has developed an innovative anti-fibrotic and anti-tumour treatment by binding a...

Insilico Medicine And SK Biopharmaceuticals to collaborate in $2.5bn deal

biotech Jim Cornall -
Insilico Medicine and SK Biopharmaceuticals have announced a research and development collaboration at the BIO 2026 International Convention to discover AI-enabled innovative drug candidates...

Kither Biotech completes phase 1 trial of inhaled peptide therapy for respiratory diseases

biotech Jim Cornall -
Kither Biotech Pty Ltd and Kither Biotech srl have announced the successful completion of their phase 1 clinical study of KIT2014 in healthy participants. KIT2014...

Houdini Bio launches to solve therapeutic and commercial genetic medicine bottlenecks

biotech Jim Cornall -
Houdini Bio has announced its official launch, having raised approximately £1.5m in non-dilutive grant funding and capital from an oversubscribed pre-seed round. The funding enables...

Base to Base biotech podcast 64: Solving logistics challenges

biotech Jim Cornall -
This week, we have a conversation with Bora Pharmaceuticals’ chief commercial officer Jean-Baptiste (JB) Agnus. Base to Base biotech podcast 64: Solving logistics | RSS.com Bora...

Preclinical results for novel therapeutic candidate for rare neurodevelopmental disorders

biotech Jim Cornall -
JW Pharmaceutical has presented preclinical findings and its global development strategy for DDC-02, a therapeutic candidate for rare neurodevelopmental disorders, at the World Orphan...
- Advertisement -spot_img

Latest Articles

Load more